Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,628 across all filing types
Latest filing 2006-02-01 Capital/Financing Update
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Announcement
Capital/Financing Update Classification · 95% confidence The document is an announcement by Huali Holdings (Group) Limited regarding connected transactions involving acquisitions of equity interests in subsidiaries. It details agreements, parties involved, transaction terms, and reasons for acquisitions. The content focuses on corporate transactions and related disclosures under the Listing Rules, specifically mentioning connected transactions and their compliance with regulatory requirements. There is no presentation of financial statements or detailed financial performance data, nor is it a report or transcript. The document is a formal announcement of corporate transactions, fitting the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as acquisitions.
2006-02-01 English
Announcement
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of the company's compliance adviser. It details the termination of the previous compliance adviser agreement and the appointment of a new compliance adviser. There is no financial data, report, or detailed analysis included. The document is short (2037 characters) and serves as a regulatory announcement about management/advisory changes rather than a financial report or detailed management discussion. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2006-01-06 English
Unusual volume movement
Regulatory Filings Classification · 95% confidence The document is a short announcement from Huali Holdings in response to a request from the Stock Exchange of Hong Kong regarding unusual trading volume. It confirms the company is not aware of any price-sensitive information or undisclosed negotiations. Since it is a general regulatory announcement regarding market activity that does not fit into specific categories like earnings, dividends, or share repurchases, it falls under the fallback category for regulatory filings.
2005-12-12 English
IPO Allotment Results
Capital/Financing Update Classification · 95% confidence The document is an announcement related to the listing of Huali Holdings (Group) Limited on the Main Board of The Stock Exchange of Hong Kong Limited by way of public offer and placing. It details the number of shares offered, offer price, underwriting arrangements, application results, basis of allocation of shares, and procedures for collection of share certificates and refund cheques. The content focuses on the share offer, allocation, and listing process rather than financial results or management commentary. This type of document is a capital market announcement related to fundraising and share issuance activities. It is not a full financial report, earnings release, or regulatory filing unrelated to capital raising. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the share offer and placing, supporting a high confidence in this classification.
2005-11-01 English
New Listing
Regulatory Filings Classification · 95% confidence The document is a short announcement from a stock exchange regarding the commencement of trading for a newly listed company (Huali Holdings). It does not contain financial statements, management reports, or proxy materials, but rather serves as a regulatory notification of a listing event. Since it does not fit into specific categories like M&A or share buybacks, it falls under the general regulatory filing category.
2005-10-31 English
Announcement
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Huali Holdings (Group) Limited regarding the final offer price, allocation results, and the commencement of trading for a new listing. This relates to the issuance of new shares and the capital structure of the company during an IPO process. Since it details the share allocation and the mechanics of the share issue/listing, it falls under the category of Share Issue/Capital Change.
2005-10-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.